Literature DB >> 23544812

Acute lymphoblastic leukemia in infants: 20 years of experience.

Amanda Ibagy1, Denise B Silva, Jackline Seiben, Ana P F F Winneshoffer, Tatiana E J B Costa, Juliana S Dacoregio, Imaruí Costa, Daniel Faraco.   

Abstract

OBJECTIVE: To analyze patients younger than 2 years with acute lymphoblastic leukemia, treated in the period between 1990 and 2010 in a state reference center.
METHODS: This was a clinical-epidemiological, cross-sectional, observational, and descriptive study. It included patients younger than 2 years with acute lymphoblastic leukemia, treated in the period of 1990 to 2010 in a pediatric oncology unit of a state reference center, totaling 41 cases.
RESULTS: All patients were white ethnicity, and 60.9% were females. Regarding age, 24.38% were younger than 6 months, 17.07% were between 6 months and 1 year, and 58.53% were older than 1 year. The age of 6 months was statistically significant for the outcome of death. Predominant signs and symptoms were fever, bruising, and petechiae. A leukocyte count > 100,000 was found in 34.14% of cases, hemoglobin count < 11 in 95.13%, and platelet count < 100,000 in 75.61. Infiltration of central nervous system was present in 12.91% of patients. According to the lineage, B-cell lineage predominated (73%), but the T-cell line was statistically significant for death. 39% of patients had disease recurrence. In relation to vital status, 70.73% of the patients died; septic shock was the main cause.
CONCLUSIONS: Acute lymphoblastic leukemia in infants has a high mortality rate, especially in children under 1 year and those with T-cell derived lineage.
Copyright © 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23544812     DOI: 10.1016/j.jped.2013.02.010

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  2 in total

Review 1.  Facial paralysis as a presenting symptom of infant leukemia: A case report and literature review.

Authors:  Liyuan Wang; Zhiling Wang; Chaomin Wan; Xiaotang Cai; Ge Zhang; Chunqi Lai
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

2.  Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.

Authors:  Beatriz Maria Dias Nogueira; Laudreísa da Costa Pantoja; Emerson Lucena da Silva; Fernando Augusto Rodrigues Mello Júnior; Eliel Barbosa Teixeira; Alayde Vieira Wanderley; Jersey Heitor da Silva Maués; Manoel Odorico de Moraes Filho; Maria Elisabete Amaral de Moraes; Raquel Carvalho Montenegro; André Salim Khayat; Caroline Aquino Moreira-Nunes
Journal:  Genes (Basel)       Date:  2021-10-17       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.